Tag Results:

Catalyst Corner

The FDA Launches a Digital Center of Excellence

The FDA sent out a recent update announcing the formation of a Digital Health Center of Excellence. The goal of the Digital Health Center is to “Empower stakeholders to advance health care by fostering responsible and high-quality digital health innovation.”

Welcome to the “New Normal”

Many of us may not have imagined the global situation with COVID-19. It is impacting all aspects of our professional and personal lives. Getting accustomed to the “new normal” of social distancing and stay-at-home orders during the COVID-19 pandemic is likely challenging for many Americans.

Flu Fighters: Pharmacists Are a Key Ingredient

-AMAZONPOLLY-ONLYWORDS-START--AMAZONPOLLY-ONLYWORDS-END-Recent news from the Centers for Disease Control and Prevention (CDC) confirmed what circulating news reports were predicting: an early-onset flu season. What remains...

Patient Satisfaction Better with Pharmacist Discussion

Results recently released from the annual J.D. Power 2019 U.S. Pharmacy Study showed that patients enjoy visiting brick-and-mortar pharmacies and find a great deal...

Lack of Access to Pharmacies Impacts Adherence

EARLIER THIS YEAR, THE Centers for Medicare & Medicaid Services (CMS) Office of the Actuary’s estimated that national health expenditures may reach $6 trillion...

Pharmacy HIT Collaborative Updates Roadmap

The Pharmacy Health Information Technology (HIT) Collaborative released its updated integration roadmap in mid−November, entitled, “The Roadmap for Pharmacy Health Information Technology Integration in U.S....

In the Works: Major Change to the NDC Number

It may not be exciting or cutting-edge except to those of us in information technology, but the pharmaceutical supply chain and pharmacy profession’s operations...

Are You Ready for the DQSA?

The Drug Quality and Security Act (DQSA) was signed into law on Nov. 27, 2013. The purpose of the DQSA is to address issues related to drug compounding oversight, and incorporates a national prescription drug “track and trace” system inclusive of standards for prescription drug wholesale distributors and third-party logistics (3PL) providers. It amends the Food, Drug & Cosmetic Act (FD&C Act).